Alere (ALR) : During the past 4 weeks, traders have been relatively bearish on Alere (ALR), hence the stock is down -10.75% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -14.64% relative to the S&P 500. The 4-week change in the price of the stock is -7.75% and the stock has fallen -14.7% in the past 1 week.
The stock has recorded a 20-day Moving Average of 8.31% and the 50-Day Moving Average is 9.75%. Alere Inc. has dropped 3.85% during the last 3-month period . Year-to-Date the stock performance stands at -4.07%.
Alere (NYSE:ALR): stock turned positive on Friday. Though the stock opened at $36.55, the bulls momentum made the stock top out at $37.56 level for the day. The stock recorded a low of $35.9219 and closed the trading day at $37.5, in the green by 2.57%. The total traded volume for the day was 1,258,087. The stock had closed at $36.56 in the previous days trading.
Alere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time, deliver care, and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its 50/50 joint venture with The Procter & Gamble Company (P&G).